Gaurav Parashar

760 total citations
26 papers, 597 citations indexed

About

Gaurav Parashar is a scholar working on Molecular Biology, Plant Science and Pharmacology. According to data from OpenAlex, Gaurav Parashar has authored 26 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 6 papers in Plant Science and 5 papers in Pharmacology. Recurrent topics in Gaurav Parashar's work include Epigenetics and DNA Methylation (5 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (3 papers). Gaurav Parashar is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (3 papers). Gaurav Parashar collaborates with scholars based in India, Egypt and Saudi Arabia. Gaurav Parashar's co-authors include Nidarshana Chaturvedi Parashar, Neena Capalash, Hardeep Singh Tuli, Manoj Kumar, Katrin Sak, Diwakar Aggarwal, Ginpreet Kaur, Vaishali Aggarwal, Jagjit Kaur and Anju Shrivastava and has published in prestigious journals such as Experimental Cell Research, Life Sciences and European Journal of Medicinal Chemistry.

In The Last Decade

Gaurav Parashar

25 papers receiving 584 citations

Peers

Gaurav Parashar

PHARM

Nidarshana Chaturvedi Parashar India

Sonam Mittal India

Guoguo Jin China

Guo-Ping Yin China

Hui‐Jye Chen Taiwan

Shyam N. Sundar United States

Benjaporn Buranrat Thailand

Wen‐Chi Wei Taiwan

Haitang Xie China

Mayilaadumveettil Nishana India

Nidarshana Chaturvedi Parashar India

Gaurav Parashar

335 ×0.9

87 ×0.9

PHARM

69 ×1.0

84 ×1.4

33 ×0.6

Citations per year, relative to Gaurav Parashar Gaurav Parashar (= 1×) peers Nidarshana Chaturvedi Parashar

Countries citing papers authored by Gaurav Parashar

Since Specialization

Citations

This map shows the geographic impact of Gaurav Parashar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaurav Parashar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaurav Parashar more than expected).

Fields of papers citing papers by Gaurav Parashar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaurav Parashar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaurav Parashar. The network helps show where Gaurav Parashar may publish in the future.

Co-authorship network of co-authors of Gaurav Parashar

This figure shows the co-authorship network connecting the top 25 collaborators of Gaurav Parashar. A scholar is included among the top collaborators of Gaurav Parashar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaurav Parashar. Gaurav Parashar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Majmudar, Maulik D., Naina Patel, A. V. Ramachandran, et al.. (2025). Cancer Stem Cell Regulation as a Target of Therapeutic Intervention: Insights into Breast, Cervical and Lung Cancer. Cell Biochemistry and Biophysics. 83(2). 1521–1535. 5 indexed citations

Munshi, Manit, Ashish R. Prajapati, Abhik Mukherjee, et al.. (2024). Hormones as a double-edged sword: the role of hormones in cancer progression and the potential of targeted hormone therapies. Medical Oncology. 41(11). 283–283. 1 indexed citations

Yadav, Vikas, Manoj Kumar Jena, Gaurav Parashar, et al.. (2023). Emerging role of microRNAs as regulators of protein kinase C substrate MARCKS and MARCKSL1 in cancer. Experimental Cell Research. 434(2). 113891–113891. 3 indexed citations

Kumar, Ajay, Bunty Sharma, Ujjawal Sharma, et al.. (2023). Apoptotic and antimetastatic effect of cucurbitacins in cancer: recent trends and advancement. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(9). 1867–1878. 12 indexed citations

Tuli, Hardeep Singh, Katrin Sak, Vivek Kumar Garg, et al.. (2022). Ampelopsin targets in cellular processes of cancer: Recent trends and advances. Toxicology Reports. 9. 1614–1623. 8 indexed citations

Aggarwal, Vaishali, Hardeep Singh Tuli, Mehmet Varol, et al.. (2021). NOTCH signaling: Journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic target. Critical Reviews in Oncology/Hematology. 164. 103403–103403. 21 indexed citations

Prasad, Rajendra, et al.. (2021). Atypical Case of Highly Mutated h-TERT Promoter in Germline Genome from Buccal Mucosa Cancer. Indian Journal of Clinical Biochemistry. 38(3). 400–404.

Tuli, Hardeep Singh, Vaishali Aggarwal, Gaurav Parashar, et al.. (2021). Xanthohumol: A Metabolite with Promising Anti-Neoplastic Potential. Anti-Cancer Agents in Medicinal Chemistry. 22(3). 418–432. 11 indexed citations

Bhatia, Rohit, Sankha Shubhra Chakrabarti, Upinder Kaur, et al.. (2021). Multi-Target Directed Ligands (MTDLs): Promising Coumarin Hybrids for Alzheimer’s Disease. Current Alzheimer Research. 18(10). 802–830. 21 indexed citations

10.

Tuli, Hardeep Singh, Sonam Mittal, Diwakar Aggarwal, et al.. (2020). Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Seminars in Cancer Biology. 73. 196–218. 78 indexed citations

11.

Parashar, Nidarshana Chaturvedi, et al.. (2020). Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2. Infection Genetics and Evolution. 85. 104497–104497. 15 indexed citations

12.

Chakrabarti, Sankha Shubhra, Upinder Kaur, Anindita Banerjee, et al.. (2020). COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?. Aging and Disease. 11(3). 480–480. 33 indexed citations

13.

Aggarwal, Vaishali, Hardeep Singh Tuli, Jagjit Kaur, et al.. (2020). Garcinol Exhibits Anti-Neoplastic Effects by Targeting Diverse Oncogenic Factors in Tumor Cells. Biomedicines. 8(5). 103–103. 64 indexed citations

14.

Tuli, Hardeep Singh, Vaishali Aggarwal, Jagjit Kaur, et al.. (2020). Baicalein: A metabolite with promising antineoplastic activity. Life Sciences. 259. 118183–118183. 71 indexed citations

15.

Parashar, Nidarshana Chaturvedi, Gaurav Parashar, Harsh Nayyar, & Rajat Sandhir. (2017). N 6 -adenine DNA methylation demystified in eukaryotic genome: From biology to pathology. Biochimie. 144. 56–62. 19 indexed citations

16.

Parashar, Gaurav & Neena Capalash. (2015). Promoter methylation-independent reactivation of PAX1 by curcumin and resveratrol is mediated by UHRF1. Clinical and Experimental Medicine. 16(3). 471–478. 29 indexed citations

17.

Shukla, Ashutosh K., Gaurav Parashar, Ajit Kumar Shasany, et al.. (2013). A transcriptomic approach for exploring the molecular basis for dosha-balancing property-based classification of plants in Ayurveda. Molecular Biology Reports. 40(4). 3255–3262. 13 indexed citations

18.

Parashar, Gaurav & Neena Capalash. (2012). Expression of the TIMP2 gene is not regulated by promoter hypermethylation in the Caski cell line. Oncology Letters. 3(5). 1079–1082. 6 indexed citations

19.

Nikbakht, Mohsen, et al.. (2010). Reversal of Hypermethylation and Reactivation of the RARβ2 Gene by Natural Compounds in Cervical Cancer Cell Lines. Folia Biologica. 56(5). 195–200. 64 indexed citations

20.

Bhandari, Shashikant V., et al.. (2009). Design, synthesis and pharmacological screening of potential anticonvulsant agents using hybrid approach. European Journal of Medicinal Chemistry. 45(3). 857–863. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact